Skip to content

Rao Lab

Division of Signaling and Gene Expression at the La Jolla Institute for Immunology

Menu
  • Overview
  • Research
    • Regulation of NFAT and NFkB
    • Store-Operated Calcium Entry
    • NFAT and Cancer Immunotherapy
    • Regulation of gene expression in T and B cells
    • TET family of DNA methylcytosine oxidases
  • News
  • Lab Members
    • Alumni
  • Publications
  • Living in San Diego
  • About

Category: Research

LJI investigators reveal that TET proteins regulate factors essential for normal antibody production

May 7, 2019June 25, 2019Research

Apr 26, 2019 // Science Immunology New study sheds light on what goes awry in malignancies marked by TET mutation LA JOLLA, CA—A family of TET proteins regulates gene expression in many cell types by influencing chromosome structure. TET proteins […]

Scientists devise strategies to counteract T Cell exhaustion in CAR T cancer therapies

May 7, 2019June 25, 2019Research

Feb 27, 2019 La Jolla Institute scientists show that deleting troublesome proteins in a mouse model can shrink tumors and prolong survival. LA JOLLA, CA – A growing number of cancer patients are being offered a promising new treatment called […]

La Jolla Institute Receives $ 4.5 Mill Cancer Moonshot Award

May 7, 2019June 25, 2019Research

Oct 18, 2018 The grant will help improve existing immunotherapeutic options; accelerate the development of novel cancer vaccines and personalized therapies for the treatment of head and neck cancer LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) and UC San […]

Hugo Sepulveda named PEW Latin American Fellow in Biomedical Sciences

August 13, 2018June 25, 2019Research

Hugo Sepúlveda receives prestigious fellowship in recognition of his innovative research LA JOLLA, CA— June 14, 2018 Postdoctoral researcher Hugo Sepúlveda, Ph.D., has been named a 2018 Pew Latin American Fellow in Biomedical Sciences, the Pew Charitable Trust announced today. […]

Posts navigation

1 2 3 4 5

Follow us on Twitter!

AnjanaRaoLab Follow

@ ·
now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter
Load More...